Synthetic peptide corresponding to N-terminal residues of human SCXA
Our Abpromise guarantee covers the use of ab58655 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use at an assay dependent concentration. Predicted molecular weight: 22 kDa.Can be blocked with SCXA peptide (ab214116). IP enrichment could be done before running a reducing gel. The positive control is purified protein or overpressed cell lysate.|
|ELISA||Use at an assay dependent concentration.|
|IHC-M||Use at an assay dependent concentration. PubMed: 21412429|
|ICC||Use at an assay dependent concentration. PubMed: 21412429|